Grossebrummel, H., Peter, T., Mandelkow, R., Weiss, M., Muzzio, D. O., Zimmermann, U., . . . Stope, M. B. (2015). Cytochrome P450 17A1 inhibitor abiraterone attenuates cellular growth of prostate cancer cells independently from androgen receptor signaling by modulation of oncogenic and apoptotic pathways. Web
Citación estilo ChicagoGrossebrummel, Hannah, et al. Cytochrome P450 17A1 Inhibitor Abiraterone Attenuates Cellular Growth of Prostate Cancer Cells Independently From Androgen Receptor Signaling By Modulation of Oncogenic and Apoptotic Pathways. 2015.
Cita MLAGrossebrummel, Hannah, et al. Cytochrome P450 17A1 Inhibitor Abiraterone Attenuates Cellular Growth of Prostate Cancer Cells Independently From Androgen Receptor Signaling By Modulation of Oncogenic and Apoptotic Pathways. 2015.